Tracking the PBYI option chain helps you see every strike and expiry on Puma Biotechnology Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Puma Biotechnology Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of PBYI options activity at a glance. Use our scanner to monitor the PBYI option chain in real time and filter for the PBYI options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For PBYI stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the PBYI option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where PBYI stock options are being actively traded and where they are not.
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd.
The company was founded in 2010 and is headquartered in Los Angeles, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Puma Biotechnology Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen PBYI options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of PBYI stock options — let the full option chain come to you, pre-filtered and ready to trade.
